$9.21
0[0.00%]
At close: Apr 22
$9.21
0[0.00%]
PreMarket: 4:00PM EDT
Accolade
(NASDAQ:ACCD)Latest News for Accolade Stock (NASDAQ:ACCD)
Accolade Stock (NASDAQ: ACCD)
Categories: All
Monday, April 22, 2024
Monday, February 26, 2024
- Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)Benzinga Insights - Feb 26, 2024, 2:01PM
- Accolade shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $16 price target.Benzinga Newsdesk - Feb 26, 2024, 11:37AM
- Leerink Partners Initiates Coverage On Accolade with Outperform Rating, Announces Price Target of $16Benzinga Newsdesk - Feb 26, 2024, 7:48AM
Friday, January 19, 2024
Tuesday, January 09, 2024
- Nasdaq Edges Higher; Cutera Shares JumpAvi Kapoor - Jan 9, 2024, 3:10PM
- Truist Securities Maintains Buy on Accolade, Raises Price Target to $16-Report Released on 8 January 2024Benzinga Newsdesk - Jan 9, 2024, 2:33PM
- Crude Oil Gains Over 2%; TD SYNNEX Posts Downbeat SalesAvi Kapoor - Jan 9, 2024, 1:08PM
- Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Jan 9, 2024, 1:00PM
- Accolade shares are trading higher after the company reported Q3 earnings.Benzinga Newsdesk - Jan 9, 2024, 11:13AM
- Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Jan 9, 2024, 10:59AM
- Truist Securities Maintains Buy on Accolade, Raises Price Target to $16Benzinga Newsdesk - Jan 9, 2024, 10:32AM
- Why Healthcare Technology Company Accolade Shares Are Surging TodayLekha Gupta - Jan 9, 2024, 9:51AM
- Piper Sandler Maintains Overweight on Accolade, Raises Price Target to $15Benzinga Newsdesk - Jan 9, 2024, 8:39AM
- Wells Fargo Maintains Equal-Weight on Accolade, Raises Price Target to $12Benzinga Newsdesk - Jan 9, 2024, 8:37AM
- Raymond James Maintains Outperform on Accolade, Raises Price Target to $16Benzinga Newsdesk - Jan 9, 2024, 8:07AM
Monday, January 08, 2024
- Accolade: Q3 Earnings InsightsBenzinga Insights - Jan 8, 2024, 4:15PM
- Accolade Sees FY24 Revenue $411M-$415M Vs $412.67M Est.Benzinga Newsdesk - Jan 8, 2024, 4:07PM
- Accolade Sees Q4 Revenue $121.5M-$125.5M Vs $126.33M Est.Benzinga Newsdesk - Jan 8, 2024, 4:06PM
- Accolade Reports Q3 EPS $(0.28) Up From $(0.56) YoY, Revenue $99.4M Beats $96.238M EstimateBenzinga Newsdesk - Jan 8, 2024, 4:05PM
- Earnings Scheduled For January 8, 2024Benzinga Insights - Jan 8, 2024, 6:32AM
Friday, January 05, 2024
Thursday, January 04, 2024
Thursday, December 07, 2023
Tuesday, November 28, 2023
Wednesday, November 22, 2023
Tuesday, November 14, 2023
Monday, October 16, 2023
Tuesday, October 10, 2023
Thursday, October 05, 2023
- Canaccord Genuity Maintains Buy on Accolade, Lowers Price Target to $17Benzinga Newsdesk - Oct 5, 2023, 2:32PM
- Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 5, 2023, 1:22PM
- Raymond James Maintains Outperform Rating for Accolade: Here's What You Need To KnowBenzinga Insights - Oct 5, 2023, 1:00PM
- Accolade shares are trading lower after the company reported Q2 financial results and issued Q3 guidance. Also, Raymond James and Truist Securities lowered their respective price targets on the stock.Benzinga Newsdesk - Oct 5, 2023, 11:43AM
- Truist Securities Maintains Buy on Accolade, Lowers Price Target to $15Benzinga Newsdesk - Oct 5, 2023, 8:44AM
- Stephens & Co. Reiterates Overweight on Accolade, Maintains $18 Price TargetBenzinga Newsdesk - Oct 5, 2023, 8:32AM
- Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 5, 2023, 8:15AM
- Raymond James Maintains Outperform on Accolade, Lowers Price Target to $12Benzinga Newsdesk - Oct 5, 2023, 7:57AM
- MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionLisa Levin - Oct 5, 2023, 6:03AM
- Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into ThursdayLisa Levin - Oct 5, 2023, 5:08AM
Wednesday, October 04, 2023
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Oct 4, 2023, 5:31PM
- Why Accolade Stock Is Falling After-HoursRyan Gustafson - Oct 4, 2023, 4:37PM
- Accolade shares are trading lower after the company reported Q2 financial results and issued Q3 guidance.Benzinga Newsdesk - Oct 4, 2023, 4:29PM
- Accolade Sees Q3 Revenue $95M-$97M vs $96.57M Est.; Sees FY24 Revenue $410M-$414M vs $412.52M Est.Bill Haddad - Oct 4, 2023, 4:11PM
- Accolade Q2 EPS $(0.43), Sales $96.90M Beat $94.09M EstimateBill Haddad - Oct 4, 2023, 4:10PM
- Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallLisa Levin - Oct 4, 2023, 9:46AM